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Introduction:Aftermajor liver surgery, there are risks of both postoperative bleeding and thrombosis. Routine co-
agulation monitoring is indicated, but may not provide adequate clinical guidance. Thus, we described the
clotting status in a pilot study using broader coagulation testing.Weanalysed the temporal pattern of coagulation
tests to assess whether thromboelastometry (ROTEM®) would improve the quality of the postoperative moni-
toring of the coagulation status in patients undergoing major hepatic resections.
Material and methods: Sixteen patients undergoing major liver resections were examined prior to surgery, on
postoperative day 1, and subsequently, every three postoperative days during hospitalization. At the same
time, the clinical signs of bleeding and thrombotic complications were monitored.
Results: On postoperative day 1, increases in bilirubin, PT-INR, APTT, and D-dimers were observed, together with
concomitant decreases inﬁbrinogen, platelet count, antithrombin (AT), protein C and protein S compared to pre-
operative values. On postoperative days 4 and 7, all of the variables had returned to the normal range except for
D-dimers, AT and protein C. The ROTEM®median values remained within the normal range. There were no sig-
niﬁcant episodes of postoperative bleeding. Two patients were diagnosed with a pulmonary embolism.
Conclusion: Despite the abnormalities observed in routine coagulation monitoring, thromboelastometry indicat-
ed a balanced coagulation status following major hepatic surgery. The levels of both pro- and anticoagulant
proteins changed over time during this period. The exact clinical role for thromboelastometry in major hepatic
surgery remains to be established.© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, an increasing number of liver resections have been
performed as a consequence of the improvement of surgical techniques,
medical imaging, and chemotherapy aswell as a consequence of chang-
es in the selection criteria [1]. Major hepatic resections have been asso-
ciated with a high risk of postoperative liver insufﬁciency, and this risk
is directly proportional to the size of the resection. There is also a direct
relationship between the degree of liver failure and mortality [2–4].
Postoperative liver insufﬁciency may involve coagulation aberrations,
and a prolonged postoperative PT-INR is commonly observed following
a major hepatectomy. This may be associated with an increased risk of
bleeding. Recent retrospective studies report a perioperative bleedinga and Intensive Care Medicine,
Stockholm, Sweden.
Dumitrescu).
. This is an open access article underincidence of approximately 6% [5,6], and the overall rate of postopera-
tive transfusion is 0.8 % [7].
In addition, there have been reports of an increased risk of throm-
botic complications following hepatic surgery, with an overall incidence
of deep venous thrombosis between 0.8% and 3.6% and a pulmonary
embolism incidence between 1.4% and 7.1% [7–9]. Concern about the
risk of postoperative bleeding has led to a controversy as to whether
routine postoperative thrombosis prophylaxis should be administered
[8,10]. After major hepatic surgery, venous thrombosis has been report-
ed to occur mainly between postoperative days 5 and 7 [9,11]. These
data indicate that patients undergoing major hepatic resections may
be affected by a postoperative hypercoagulable state despite the general
perception of hypocoagulability indicated by usual coagulation tests,
such as PT/INR. Currently, there are no conventional laboratory assays
that can predict the occurrence of a venous thromboembolism.
There are a few prospective studies that focus on deﬁning the
coagulation status of patients undergoing major liver surgery.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Patients: characteristics, diagnoses, and surgical and transfusion aspects.
Patients
Sex
Male 6
Female 10
Age⁎(years) 66 (46–80)
Body mass index⁎(kg/m2) 25 (18.5-32.7)
Diagnosis
Metastatic cancer 10
Hepatocellular carcinoma 1
Cholangiocarcinoma 3
Benign conditions⁎⁎ 2
Type of surgery
Hemihepatectomy 8
Extended hemihepatectomy 8
Intraoperative bleeding⁎(ml) 600 (100–4500)
Intraoperative transfusion
PRC⁎(ml) (n = 2) 1250 (1000–1500)
Plasma⁎(ml) (n = 2) 875 (750–1000)
Platelets (ml) 0
Postoperative transfusion
PRC⁎(ml) (n = 4) 500 (500–500)
Plasma (ml) 0
Platelets (ml) 0
PRC = packed red blood cells.
⁎ Median (range).
⁎⁎ (chronic inﬂammation, IgG4+ sclerosing cholangitis).
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[12] and in patients undergoing liver resections for primary and second-
ary malignancies [13].
Thromboelastography (TEG®) is a viscoelastic method for
haemostatic testing in whole blood that provides a global assessment
of coagulation function. It has long been used postoperatively following
cardiac surgery, during liver transplantation, and in acute trauma pa-
tients to mainly detect hypocoagulation and to guide transfusion thera-
py [14–19]. Thromboelastography (TEG®) is reported to be able to
detect hypercoagulation and predict thromboembolic events in surgical
patients [20–22]. However, there are other reports that have showed
that the predictive capacity may be highly variable [23].
Rotation thromboelastometry (ROTEM®) is based on the same prin-
ciple as thromboelastography (TEG®). Depending on themethod of ini-
tiating coagulation, different types of thromboelastometric curves
result, which reﬂect the intrinsic pathway of coagulation (INTEM), the
extrinsic pathway of coagulation (EXTEM), or the ﬁbrinogen functional-
ity (FIBTEM). Nevertheless, there are differences in the sensitivity
between TEG® and ROTEM®, and thus, the results are not always com-
parable [14]. It has recently been found that the functional ﬁbrinogen of
TEG® may overestimate ﬁbrinogen levels compared to the plasma ﬁ-
brinogen concentration [24].
We prospectively examined consecutive patients scheduled for a
major liver resection longitudinally during hospitalization in a descrip-
tive pilot study.We used a battery of routine coagulation-related analy-
ses and ROTEM® and simultaneously recorded the clinical signs of
bleeding and thromboembolism. The protocol extended frompreopera-
tive to every 3rd day, postoperatively.
Our hypothesis was that the combination of routine chemistry and
ROTEM®may increase the quality of the surveillance of the coagulation
status following liver surgery. The aim of our study was to assess
whether ROTEM®, as a global test of coagulation would improve the
predictability of postoperative bleeding or pulmonary embolism after
hemihepatectomy and extended hemihepatectomy.
2. Materials and Methods
2.1. Subjects
Patients (n = 16) scheduled for extensive liver surgery, namely,
hemihepatectomy and extended hemihepatectomy, at Karolinska Uni-
versity Hospital Huddinge, were examined. The exclusion criteria
were pre-existing coagulopathy and the use of anticoagulation drugs
or platelet aggregation inhibitors. The patients’ characteristics are pro-
vided in Table 1. The patients provided written informed consent after
having been informed about the study protocol, orally and in writing.
The protocol was performed in accordance with the Helsinki Declara-
tion and was approved by the Regional Ethics Committee in
Stockholm, Sweden.
2.2. Protocol
Blood samples for the coagulation status, as described below, were
collected via a 12 F central venous catheter from all patients on the
morning before surgery after the induction of anaesthesia, on postoper-
ative day 1, and thereafter, every third postoperative day (0, 1, 4, 7, 10,
13, 16, 19 etc.) as long as thepatientwashospitalised and the central ve-
nous catheter remained in place.
Intraoperative and postoperative bleeding were strictly monitored,
and the clinical parameters indicative of thrombosis (deep vein throm-
bosis and thromboembolism) were recorded in conjunction with each
blood sampling. These included the diameters of the legs, respiratory
rate, oxygen administration, ECG, and body temperature.
All patients were treated according to the local protocol for liver re-
sections at Karolinska University Hospital and this was not affected by
the study. All patients received a thoracic epidural catheter before theinduction of general anaesthesia. Ringer-Acetate and Volulyte® (6 %
hydroxyethyl starch 130/0.4 in a balanced electrolyte solution) were
used as intraoperative ﬂuids. Central venous pressure was kept below
5 cm of water during the hepatic resection. Blood pressure was moni-
tored via a 20G catheter in the left radial artery. All patients were
extubated after the surgical procedure, Glucose 5% was administered
during the initial 24 hours and as soon as the patients were circulatorily
stable enteral nutritionwas initiated. Analgesiawas administered via an
epidural catheter for 5–7 days postoperatively. All patients received
thrombosis prophylaxis with Fragmin ® (dalteparin) 5000 IE starting
on the day before surgery and continuing regularly every day at 20:00
for as long as the patient was hospitalized.
2.3. Analyses
The following analyses were included at each blood sampling: total
serum bilirubin (BIL-T, Roche Diagnostics on Modular P EVO, Roche Di-
agnostics, Mannheim, Germany), prothrombin time-international nor-
malized ratio (PT-INR, Owren method Stago SPA, Diagnostica Stago,
Asnières sur Seine, France on Sysmex CS 2100i, Sysmex Corporation,
Kobe, Japan), activated partial thromboplastin time (aPTT) (Stago PTT
automate, Diagnostica Stago, Asnières sur Seine, France, on Sysmex CS
2100i from Sysmex Corporation, Kobe, Japan), ﬁbrinogen (Claussmeth-
od, Siemens Thrombin reagent on Sysmex CS 2100i fromSysmex Corpo-
ration, Kobe, Japan), platelet count (on Sysmex XE 5000, Sysmex
Corporation, Kobe, Japan), antithrombin (AT) (anti-Xa based metod,
Innovance Siemens on Sysmex CS 2100i Sysmex Corporation, Kobe,
Japan), protein C (Berichrom PC, Siemens Healthcare Diagnostics Prod-
ucts GmbH on BCS® XP System, Siemens Healthcare Diagnostics
Products GmbH, Marburg, Germany), protein S (Coamatic PS-free,
Chromogenix, Instrumentation Laboratory SpA Milano, Italy on BCS®
XP System from Siemens Healthcare Diagnostics Products GmbH, Mar-
burg, Germany), D-dimers (Roche Tinaquant reagents fromRoche Diag-
nostics Ltd. Rotkreuz, Switzerland on Sysmex CS 2100i from Sysmex
Corporation, Kobe, Japan), and thromboelastometry, which was per-
formed using a ROTEM® delta device (Pentapharm GmbH, Munich,
Germany). Stimulating coagulation for each thromboelastometric
assaywas performed in the samemanner as for routine clinical tests, ac-
cording to the instructions of the manufacturer (ellagic acid for INTEM,
tissue factor for EXTEM, and tissue factor and cytochalasin for FIBTEM).
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EXTEM were: i) the clotting time, CT, which represented the time, in
seconds, from the start of the analysis to the recognizable initiation of
clotting; ii) clot formation time, CFT,which represented the time, in sec-
onds, from the initiation of clotting until a clot ﬁrmness of 20 mmwas
established; and iii) maximum clot ﬁrmness (MCF), which represented
themaximal amplitude (mm) of the graphical trace of the clot ﬁrmness.
For FIBTEM, only the maximum clot ﬁrmness (MCF) was investigated.
Brieﬂy, disrupted activation of coagulationwas indicated by a prolonged
clotting time (CT), an abnormal clot formation was indicated by a
prolonged clot formation time (CFT), and reduced clot strength was in-
dicated by decreased maximum clot ﬁrmness (MCF). Conversely, the
hypercoagulable state may be indicated by a shortening of the CT and
CFT and an increase in MCF [25].
The ROTEM®assaywas performed at theDepartment of Transfusion
Medicine, while the other analyses were performed at the Department
of Clinical Chemistry.
2.4. Statistics
The GraphPad Prism 5® statistical software package was used
(GraphPad Software, Inc., San Diego, CA) for calculations. Statistical
comparisons for the coagulation parameters studied were performed
for days 0–7 using Friedman’s ANOVA and Dunn’s post-hoc multiple
comparison test.
3. Results
Patients scheduled for liver resection were studied longitudinally as
long as they had a functional central venous catheter (range 4–19 days).
If the postoperative course was uneventful, then they were discharged
to a convalescent clinic on the 7th -10th postoperative day. Diagnoses,
surgical procedures and intraoperative bleeding are shown in Table 1.
Results from the analysesmade by thehospital’s Department of Clin-
ical Chemistry are summarized in Fig. 1 (panels 1A, 1B and 1C) andwere
normalized with preoperative values as 100%. In electronic supplemen-
tarymaterial 2, the normal ranges of the analyses are indicated. Onpost-
operative day 1, there were increases in bilirubin, PT-INR, APTT, and D-
dimers, while ﬁbrinogen, platelet count, AT, protein C and protein S all
decreased compared with the preoperative values. On postoperative
days 4 and 7, all of the variables tended towards a normal range, except
for D-dimers, AT and protein C. The absolute values for these subjects
are given in electronic supplementary material 2. Because the increase
in D-dimers were derived and shown in the scales in Fig. 1, these values
are only provided in electronic supplementary material 2.
The results from the ROTEM® analyses are summarized in Fig. 1
(panels 1D and 1E), and were normalized with preoperative values as
100%. Although there were temporal changes in ROTEM® parameters,
the median values stayed within the normal range the entire study pe-
riod. On postoperative day 1, there were increases in CFT-INTEM and
CFT-EXTEM, while MCF-INTEM, MCF-EXTEM, and MCF-FIBTEM all de-
creased compared with the preoperative values. For CT-INTEM and
CT-EXTEM, no signiﬁcant changes were observed compared with the
preoperative values. On postoperative days 4 and 7, all of the variables
that demonstrated a change on postoperative day 1 tended towards
the normal range. Importantly, in CT-EXTEM and FIBTEM, individual
subjects showed values that exceeded the normal range towards
hypercoagulation on postoperative days 4 and 7. The absolute values
for these subjects are provided in electronic supplementary material 2.
For the ﬁbrinogen plasma concentration and MCF-FIBTEM, a post-
hoc analysis dichotomizing the patients according to the size of the
liver resection showed a signiﬁcant difference. The decrease was more
pronounced on postoperative day one and less of a catch-up towards
the normal range in the group with extended hemihepatectomy com-
pared with patients with a hemihepatectomy. This ﬁnding is illustratedin Fig. 2(A, B). The absolute values for these subjects are provided in
electronic supplementary material 3.
Postoperatively, no patient was re-operated due to bleeding, but
four patients were treated with packed red blood cell transfusion (for
further details, see electronic supplementarymaterial 1). The study pro-
tocol included clinical observations that are indicative of postoperative
thromboembolic complications. No patients had local signs of swelling
or discolouration of the legs, signs of right ventricular strain on the elec-
trocardiography, or an elevation of body temperature N 38 ° C when in-
vestigated at the blood sampling times. In total, 11 patients were given
extra oxygen at the blood sampling times (for further details, see elec-
tronic supplementary material 1).
Two patients who had a thoracic CT scan on postoperative days 5
and 8, respectively, due to increased oxygen administration, were con-
ﬁrmed with the diagnosis of pulmonary embolism. Both patients
underwent right hemihepatectomies. In one of these patients, CT-
EXTEM, CFT-EXTEM and MCF-FIBTEM revealed values indicating
hypercoagulation prior to the occurrence of a pulmonary embolism.
The other patient had a CT-EXTEM towards the hypercoagulation
limit, but all of the other ROTEM parameters were within the normal
range. In both patients, there was a rapid rebound of ﬁbrinogen, the
values of which exceeded the upper limit of the plasma concentration
in one patient on postoperative day 4; however, in the other patient,
MCF-FIBTEM had values indicating hypercoagulation on postoperative
day 4 and 7. Regarding the anticoagulant proteins in patients that devel-
oped a pulmonary embolism, the levels of protein C and AT were lower
than normal for both patients, while the levels of protein S were within
the normal range. The absolute values for these subjects are provided in
electronic supplementary material 4. These patients were given high-
dose low-molecular heparin from the day of diagnosis and on subse-
quent days (one of the patients was still treated within the study proto-
col, which is indicated in electronic supplementary material 2 and 4).4. Discussion
In this descriptive pilot study, the temporal pattern of the coagula-
tion status of patients undergoingmajor liver resections was character-
ized. Both procoagulation and anticoagulation were reﬂected and
compared in relationship to some of the aspects of the clinical course.
Clinically, therewere no signiﬁcant postoperative bleeding episodes.
Nevertheless, the PT – INR value and the decreasing plasmatic ﬁbrino-
gen indicated that patientsmay have a risk of bleeding on postoperative
day 1. However, this ﬁndingwas not supported by the ROTEM®param-
eters, which showed that most patients were within the normal range.
Importantly, a discrepancy between the results of the conventional co-
agulation tests and ROTEM® on postoperative day 1 was observed.
The decrease in the plasma concentration of ﬁbrinogen and the pro-
coagulant factors, was not reﬂected in the results of CT, CFT and MCF
(INTEM and EXTEM), which demonstrated only slight variations in
most of the subjects. However, not only the pro-coagulant factors
were affected; the levels of the natural anticoagulant proteins (e.g. pro-
tein C, protein S and AT) were also reduced. The haemostatic balance
may be maintained when the pro- and anticoagulant system are affect-
ed to the same extent [14]. This is probably themost important mecha-
nism behind the fact that the ROTEM®median values remained within
the normal range on postoperative day 1. Another factor that affects the
ROTEM® parameters, particularly MCF, is platelets. Although lower
compared with preoperative values, platelet counts were sufﬁciently
high enough to ensure the good strength of the cloth on postoperative
day 1 in most patients. ROTEM® evaluated the viscoelastic properties
of non-centrifugal blood, resulting in a global viewpoint over the func-
tion of the coagulation system. All of the blood cells and the complete
set of the coagulation components of the plasma were analysed within
the same sample. Thus, it must be mentioned that erythrocytes can sig-
niﬁcantly affect the coagulation process [26,27].
Fig. 1. (A-E). Perioperative changes in the coagulation parameters for patients undergoing liver surgery (n=16). Panels 1A, 1B and 1C depict the routine chemistry,while panels 1Dand 1E
depict the ROTEM® parameters. All of the values are expressed as the median and were normalized with preoperative values as 100%. The level of statistical signiﬁcance for the ANOVAs
calculated for the individual parameters are given in the parentheses in the ﬁgure panels. For panels 1D and 1E it should be emphasized that although the temporal changes in ROTEM®
parameters attained statistical signiﬁcance, themedian values stayed within the normal range the entire study period. All of the numerical values, including sampling after postoperative
day 7, are provided in Supporting Information 2 in the electronic supplement.
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an imbalance in favour of the procoagulant component in some sub-
jects. This was a reﬂection of the rapid return to normal PT-INR, and
plasma ﬁbrinogen which was unaccompanied by an equally rapid nor-
malization of the anticoagulant proteins, particularly protein C and AT,
which continued to remain low. During this period, CT-EXTEM and
MCF-FIBTEM exceeded the normal limits towards hypercoagulation
for individual patients. Nevertheless, for the majority of patients, this
potential hypercoagulation, from postoperative day 4 and onwards,was not highlighted by the ROTEM®parameters, which remainedwith-
in the normal range.
According to local clinical routines at our hospital, thrombosis pro-
phylaxis in a normal dosage was administered to all patients. However,
two of the patients came under the suspicion of having developed a
post-surgery pulmonary embolism, and a CT scan conﬁrmed these sus-
picions. The ROTEM® values for these two particular cases were very
close or exceeded the normal range towards hypercoagulation on post-
operative day four and onwards. In one patient, CT- EXTEM, CFT-EXTEM
Fig. 2. (A, B). Perioperative plasma concentrations of ﬁbrinogen (2A) andMCF-FIBTEM (2B) in patients undergoing liver surgery. Patients were grouped according to the size of the resec-
tion, and the results for the hemihepatectomy and extended hemihepatectomy (n= 8+8) are shown in blue and red, respectively. Values are provided as themean+ SD. The temporal
pattern was signiﬁcantly different between the 2 groups as tested using two-way ANOVA, (n = 5 + 6).
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the occurrence of pulmonary embolism. This demonstrated that ROTEM®
is able to signal the risk of pulmonary embolism. Anyhow, other patients
demonstrated the same coagulation pattern and had not been diagnosed
with thrombosis complications. Clearly, the risk of thromboembolic
events involves many aspects, not only concerning clotting but also the
haemodynamics and blood ﬂow in the venous system and, particularly
in the case of liver surgery, the ﬂow in the hepatic veins.
Other investigators have used thromboelastography (TEG®) to detect
the potential hypercoagulant status [13,28,29]. However, associations
with clinically relevant thromboembolic events was not reported, al-
though special coagulation tests like prothrombin fragments 1 and 2,
thrombin-antithrombin complexes and plasma von Willebrand Factor
antigen performed at the same time, suggest activation of coagulation
[13]. The potential hypercoagulation of these patients may be based on
the accentuated decrease in anticoagulant proteins accompanied by the
rapid resumptionof speciﬁc procoagulant factors’ synthesis, including fac-
tor VIII or vonWillebrand factor [12,29], which are acute phase reactants.
Unexpectedly, our study indicated thatwith regard toﬁbrinogen,which is
also an acute phase reactant, this argument may be stronger following
hemihepatectomy compared to extended hemihepatectomy. This may
potentially be related to differences in the volume of the remaining liver
tissue because ﬁbrinogen is synthesized mainly by the liver. Thus, it
may be speculated that the risk of ﬁbrinogen concentrations reach
supranormal values, thereby potentially contributing to hypercoagulation
could bemore pronounced following a hemihepatectomy. Further studies
of this speciﬁc aspect are warranted.
A recent study reports brief hypercoagulability on postoperative day
one after major hepatectomy with coagulation that was normalized
during the following days [30]. We were unable to observe any signs
of hypercoagulability on postoperative day one in our patients using
ROTEM®. In contrast, CT-INTEM and MCF-FIBTEM demonstrated
hypercoagulation values on postoperative day four and afterwards in
individual patients.
The use of ROTEM® (INTEM, EXTEM, and FIBTEM) generated rele-
vant results regarding the postoperative coagulation balance after
major liver surgery. Most of the subjects in our study were
normocoagulable according to ROTEM® throughout the postoperative
days, and this was consistent with the absence of signiﬁcant postopera-
tive bleeding. Individual patients presented ROTEM® signs that may in-
dicate an imbalance towards hypercoagulation, and one of these
patients was affected by a pulmonary embolism. Thus the results ob-
tained from ROTEM®may signal an increased risk of venous thrombo-
embolism. Future studies testing this hypothesis and the potential effect
of enhanced prevention of thromboembolism are advocated.
The strengths of our study are (i) the selected patient group
underwent major liver surgery, hemihepactomy or extended
hemihepactomy, which is the group that is at risk to develop liver insufﬁ-
ciency, thromboembolism, and/ormassive bleeding; (ii) all of the patientsreceived thrombosis prophylaxis, regardless of the clotting test results;
and (iii) bothpro- andanticoagulantmechanismswere studied longitudi-
nally and biochemically using the thromboelastometric method.
Our study also has several limitations: (i) the protocol did not allow
for differentiation between the effects of coagulation by elective surgical
trauma, in general, and the effect from the loss of liver tissue; (ii)
clotting factors and biomarkers for thrombin generation andﬁbrinolysis
were not analysed; (iii) pulmonary embolisms were not systematically
diagnosed using computer tomography for patients who required O2
administration after surgery; and (iv) echographic screening for deep
vein thrombosis in the patients included in this study was not per-
formed. Furthermore, (v) we did not evaluate the effect of administered
synthetic colloids that were routinely used at our hospital at the time of
the study on the ROTEM® parameters.5. Conclusions
Following major hepatic surgery, there were changes in the routine
coagulation parameters. The addition of ROTEM® analyses indicated
that nearly all of the patients had a balanced coagulation status. A po-
tential tendency towards hypercoagulation for individual patients was
observed and may be based on an accentuated decrease in anticoagu-
lant proteins, which was accompanied by a rapid return of speciﬁc
procoagulant factors towards normal levels. The combination of routine
coagulation monitoring and ROTEM® analyses may provide a more
complete picture of the coagulation status. Although this contributes
to our understanding of the coagulation status after major liver surgery,
this observational pilot study alone cannot provide support to the rou-
tine use of this type of enhanced monitoring in everyday clinical prac-
tice in these patients. Thus, studies that systematically combine
postoperative thromboembolic related complications and enhanced
monitoring will be necessary to support such a recommendation. It
was also observed post-hoc that the size of liver resection may be a fac-
tor to consider and that postoperative ﬁbrinogen trends are different
between hemihepatectomy and extended hepatectomy.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.thromres.2015.05.023.Conﬂicts of Interest
The authors declare that there were no conﬂicts of interest.Acknowledgements
The authors acknowledge the skilled nursing assistance of Ms.
Kristina Kilsand, Ms. Lena Nyström and Ms. Sara Rydén and the skilled
technical assistance of Ms. Gunilla Gryfelt.
407G. Dumitrescu et al. / Thrombosis Research 136 (2015) 402–407References
[1] G. Lyratzopoulos, C. Tyrrell, P. Smith, J. Yelloly, Recent trends in liver resection sur-
gery activity and population utilization rates in English regions, HPB (Oxford) 9
(2007) 277–280.
[2] S. Balzan, J. Belghiti, O. Farges, S. Ogata, A. Sauvanet, D. Delefosse, et al., The "50-50
criteria" on postoperative day 5: an accurate predictor of liver failure and death after
hepatectomy, Ann. Surg. 242 (2005) 824–828 (discussion 8–9).
[3] C. Paugam-Burtz, S. Janny, D. Delefosse, S. Dahmani, F. Dondero, J. Mantz, et al., Pro-
spective validation of the "ﬁfty-ﬁfty" criteria as an early and accurate predictor of
death after liver resection in intensive care unit patients, Ann. Surg. 249 (2009)
124–128.
[4] J.T. Mullen, D. Ribero, S.K. Reddy, M. Donadon, D. Zorzi, S. Gautam, et al., Hepatic in-
sufﬁciency and mortality in 1,059 noncirrhotic patients undergoing major hepatec-
tomy, J. Am. Coll. Surg. 204 (2007) 854–862 (discussion 62–4).
[5] A. Andres, C. Toso, B. Moldovan, E. Schiffer, L. Rubbia-Brandt, S. Terraz, et al., Compli-
cations of elective liver resections in a center with low mortality: a simple score to
predict morbidity, Arch. Surg. 146 (2011) 1246–1252.
[6] R.A. Schroeder, C.E. Marroquin, B.P. Bute, S. Khuri, W.G. Henderson, P.C. Kuo, Predic-
tive indices of morbidity and mortality after liver resection, Ann. Surg. 243 (2006)
373–379.
[7] C.W. Tzeng, M.H. Katz, J.B. Fleming, P.W. Pisters, J.E. Lee, E.K. Abdalla, et al., Risk of
venous thromboembolism outweighs post-hepatectomy bleeding complications:
analysis of 5651 National Surgical Quality Improvement Program patients, HPB (Ox-
ford) 14 (2012) 506–513.
[8] R.S. Turley, S.K. Reddy, C.K. Shortell, B.M. Clary, J.E. Scarborough, Venous thrombo-
embolism after hepatic resection: analysis of 5,706 patients, J. Gastrointest. Surg.
16 (2012) 1705–1714.
[9] E. Melloul, F. Dondero, V. Vilgrain, D.A. Raptis, C. Paugam-Burtz, J. Belghiti, Pulmo-
nary embolism after elective liver resection: a prospective analysis of risk factors,
J. Hepatol. 57 (2012) 1268–1275.
[10] S.K. Reddy, R.S. Turley, A.S. Barbas, J.L. Steel, A. Tsung, J.W. Marsh, et al., Post-
operative pharmacologic thromboprophylaxis after major hepatectomy: does pe-
ripheral venous thromboembolism prevention outweigh bleeding risks? J.
Gastrointest. Surg. 15 (2011) 1602–1610.
[11] C. Nobili, E. Marzano, E. Oussoultzoglou, E. Rosso, P. Addeo, P. Bachellier, et al., Mul-
tivariate analysis of risk factors for pulmonary complications after hepatic resection,
Ann. Surg. 255 (2012) 540–550.
[12] A. Bezeaud, M.H. Denninger, F. Dondero, V. Saada, L. Venisse, M.G. Huisse, et al., Hy-
percoagulability after partial liver resection, Thromb. Haemost. 98 (2007)
1252–1256.
[13] L. Weinberg, N. Scurrah, F.C. Parker, R. Dauer, J. Marshall, P. McCall, et al., Markers of
coagulation activation after hepatic resection for cancer: evidence of sustained up-
regulation of coagulation, Anaesth. Intensive Care 39 (2011) 847–853.
[14] S.V. Mallett, P. Chowdary, A.K. Burroughs, Clinical utility of viscoelastic tests of coag-
ulation in patients with liver disease, Liver Int. 33 (2013) 961–974.
[15] K. Gorlinger, D. Dirkmann, C. Solomon, A.A. Hanke, Fast interpretation of
thromboelastometry in non-cardiac surgery: reliability in patients with hypo-,
normo-, and hypercoagulability, Br. J. Anaesth. 110 (2013) 222–230.[16] K. Gorlinger, L. Shore-Lesserson, D. Dirkmann, A.A. Hanke, N. Rahe-Meyer, K.A.
Tanaka, Management of Hemorrhage in Cardiothoracic Surgery, J. Cardiothorac.
Vasc. Anesth. 27 (2013) S20–S34.
[17] K. Gorlinger, Coagulation management during liver transplantation,
Hamostaseologie 26 (2006) S64–S76.
[18] H. Schochl, U. Nienaber, G. Hofer, W. Voelckel, C. Jambor, G. Scharbert, et al., Goal-
directed coagulationmanagement ofmajor traumapatients using thromboelastometry
(ROTEM)-guided administration of ﬁbrinogen concentrate and prothrombin complex
concentrate, Crit. Care 14 (2010) R55.
[19] P.I. Johansson, T. Stissing, L. Bochsen, S.R. Ostrowski, Thrombelastography and
tromboelastometry in assessing coagulopathy in trauma, Scand. J. Trauma Resusc.
17 (2009).
[20] J.L. Kashuk, E.E. Moore, A. Sabel, C. Barnett, J. Haenel, T. Le, et al., Rapid
thrombelastography (r-TEG) identiﬁes hypercoagulability and predicts thrombo-
embolic events in surgical patients, Surgery 146 (2009) 764–772 (discussion 72–4).
[21] M. Toukh, D.R. Siemens, A. Black, S. Robb, M. Leveridge, C.H. Graham, et al.,
Thromboelastography identiﬁes hypercoagulablilty and predicts thromboembolic
complications in patients with prostate cancer, Thromb. Res. 133 (2014) 88–95.
[22] D. Krzanicki, A. Sugavanam, S.Mallett, Intraoperative hypercoagulability during liver
transplantation as demonstrated by thromboelastography, Liver Transpl. 19 (2013)
852–861.
[23] Y. Dai, A. Lee, L.A. Critchley, P.F. White, Does thromboelastography predict postoper-
ative thromboembolic events? A systematic review of the literature, Anesth. Analg.
108 (2009) 734–742.
[24] A. Agren, A.T. Wikman, A. Ostlund, G. Edgren, TEG(R) Functional Fibrinogen Analysis
May Overestimate Fibrinogen Levels, Anesth. Analg. 118 (2014) 933–935.
[25] T. Lang, A. Bauters, S.L. Braun, B. Potzsch, K.W. von Pape, H.J. Kolde, et al., Multi-
centre investigation on reference ranges for ROTEM thromboelastometry, Blood
Coagul. Fibrinolysis 16 (2005) 301–310.
[26] M.F. Whelihan, V. Zachary, T. Orfeo, K.G. Mann, Prothrombin activation in blood co-
agulation: the erythrocyte contribution to thrombin generation, Blood 120 (2012)
3837–3845.
[27] L. Bochsen, P.I. Johansson, A.T. Kristensen, G. Daugaard, S.R. Ostrowski, The inﬂuence
of platelets, plasma and red blood cells on functional haemostatic assays, Blood
Coagul. Fibrinolysis 22 (2011) 167–175.
[28] L. De Pietri, R. Montalti, B. Begliomini, G. Scaglioni, G. Marconi, A. Reggiani, et al.,
Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagu-
lability, hypocoagulability or normocoagulability? Eur. J. Anaesthesiol. 27 (2010)
608–616.
[29] S.G. Louis, J.S. Barton, G.M. Riha, S.L. Orloff, B.C. Sheppard, R.F. Pommier, et al., The
international normalized ratio overestimates coagulopathy in patients after major
hepatectomy, Am. J. Surg. 207 (2014) 723–727.
[30] J.S. Barton, G.M. Riha, J.A. Differding, S.J. Underwood, J.L. Curren, B.C. Sheppard, et al.,
Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Ox-
ford) 15 (2013) 865–871.
